Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Don’t Buy Into the Fantasy of Chesapeake Stock

Despite bankruptcy being a near certainty, CHK stock is drawing attention from buyers. Here's why it's a bad idea to indulge this fantasy.

PepsiCo May Offer Sturdy Shelter for the Upcoming Storm

PEP stock was not spared as the Dow tumbled 1,800 points on June 11. But the stock should recover as investors look for defensive stocks.

Wait for More Data Before Buying Paycom Software

Although the May jobs report initially has positive implications for PAYC stock, the fine print in the employment numbers makes this a tricky bet.

It’s Game on for Advanced Micro Devices Stock in a Post-Lockdown World

AMD stock has been surging during the Covid-19 pandemic. However, partnerships in the video game sector will give AMD a catalyst into 2021.

7 Great Biotech Stocks to Buy and Hold Now

As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.